A clinical comparison between Macrodantin and trimethoprim for prophylaxis in women with recurrent urinary infections

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Seventy-two patients with a history of at least three attacks of urinary infection in the previous 12 months were assigned randomly to long-term prophylaxis with 100 mg at night of either Macrodantin (34 patients) or trimethoprim (38 patients). The mean interval between symptomatic attacks while on either treatment was increased threefold compared with the pretreatment period. Macrodantin was significantly more effective (PP<0·05) in the group taking Macrodantin. In patients taking trimethoprim acquisition of resistance by faecal coliforms occurred at a rate of about 5%/month, and breakthrough infections were almost exclusively caused by trimethoprim-resistant coliforms. No acquisition of resistance occurred in patients taking Macrodantin, and the few breakthrough infections noted were due to sensitive bacteria.

This publication has 7 references indexed in Scilit: